Trial NCT03128034

View at ClinicalTrials.gov 
Org. Study IDs: 9595
Secondary IDs: 9595 NCI-2017-00452 P01CA078902 RG9217014

Last trial update was posted on 2024-01-18

MeSH Interventions

Cyclosporine Cyclosporins Fludarabine Fludarabine phosphate Mycophenolic Acid

MeSH Conditions

Acute Disease Anemia, Refractory, with Excess of Blasts Leukemia Leukemia, Lymphoid Leukemia, Myeloid Leukemia, Myeloid, Acute Leukemia, Myelomonocytic, Chronic Leukemia, Myelomonocytic, Juvenile Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma Preleukemia Recurrence Syndrome

Other Conditions

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Mixed Phenotype Acute Leukemia Myelodysplastic Syndrome With Excess Blasts Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Myeloid Leukemia Recurrent Mixed Phenotype Acute Leukemia Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Refractory Mixed Phenotype Acute Leukemia

Stopping Reasons

Administrative - FDA Comments

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID